PROTECTING YOUR RIGHT TO MEDICINES AND MEDICAL DEVICES
Wednesday, 01 April 2020

The activities carried out by Licensing and Enforcement Division (LED) for which it is competent are all documented in the Medicines and Allied Substances Control Act (Chapter 15:03). Compliance to the quality management systems is monitored by the Quality Office. Operational documentation comprises of legislation, standards, manuals, SOPs, guidelines and checklists. The MCAZ is mandated by MASCA to carry out pharmaceutical inspections, including inspections of pharmaceutical manufacturers, pharmacies, dispensing clinics, dispensing medical practitioners, public institutions, veterinary medicines general dealers (VMGD), wholesale dealers and medicine distributors. The Authority makes decisions concerning the issue or withdrawal of establishment and person’s licences or authorizations of their activities, the issue or withdrawal of GMP compliance recognition and handling suspected quality defects.

The activities and functions of the LED are guided by the multi-disciplinary Licensing and Advertising Committee and subsequently all the licensing, inspection and enforcement activities of the LED are tabled before this Committee for the purpose of decision making. This provides impartiality as the regulatory officers who review applications for licences and conduct inspections do not have decision making powers. The decisions of the Licensing and Advertising Committee are further ratified by the Authority.

The LED has three functional units; the Licensing Unit, the Enforcement Unit and the Import and Export Unit led by Chief Regulatory Officers (CROs) reporting to the Head of Licensing and Enforcement (HLED) who in turn reports to the Director-General. The responsibilities of the three units are as follows:

 

Licensing Unit Functions

  1. Verifying the completeness of applications for premises and persons licences before they are submitted for processing.
  2. Licensing of persons and premises.
  3. Inspection of premises for new applications to verify compliance with the minimum requirements for licensing.
  4. Approval of applications for the importation of unregistered medicines/donations under the provisions of section 75 of MASCA for individuals and institutions.
  5. Processing and approval of narcotic and psychotropic licences, and precursor permits.
  6. Compilation of statistics for internationally controlled substances which are submitted on a quarterly basis to the International Narcotics Control Board (INCB).
  7. Reviewing of advertising material submitted for approval.
  8. Administration of the forensic pharmacy examinations.

Enforcement Unit Functions

  1. Inspection of establishments.
  2. Product defects and recalls.
  3. Market surveillance and control.
  4. Investigation of complaints.

Import and Export Unit Functions

  1. Processing of applications for import and export of medicines.
  2. Verification of consignments at the ports of entry.
  3. Training of and liaison with port officials.

Applicable Legislation

  1. Medicines and Allied Substances Control Act (Chapter 15:03) and Regulations  click here
  2. Dangerous Drugs Act and Regulations click here
  3. Cannabis Cultivation Statutory Instrument click here

Latest News

Draft SADC Variations Guidelines

20 March 2020

Draft SADC Variations Guidelines are now available  Click the following links to download the guidelines and the comments sheet Draft SADC Variations Guidelines Draft SADC Variations Guidelines Comments Sheet

Medicines Information Bulletin - 2019

20 December 2019
Medicines Information Bulletin - 2019

Inside this issue: E-Reporting Tools Safety Notifications for Fluoroquinolones and Quinolones Antibiotics Notification of a potential risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) in patients treated...

Code of Ethics

22 August 2019
Code of Ethics

  In pursuit of promoting high ethical standards, the Authority has formulated a Code of Ethics for its employees and members of the Authority .The Authority believes that high ethical...

SADC Guideline on Product Information and Labeling

10 July 2019
SADC Guideline on Product Information and Labeling

  Southern African Development Community (SADC), as a region has harmonized medicines registration guidelines in the common technical document (CTD) format that were approved in January 2015. Nevertheless, the harmonization...

Draft Guidelines For Comments Only: Guideline for Submitting Application for Variations to Registered Medicines

17 May 2019
Draft Guidelines For Comments Only: Guideline for Submitting Application for Variations to Registered Medicines

In line with the WHO guidelines on variations and other SRA guidelines, the EVR Division is updating the MCAZ Guidelines for submitting applications for Variations to Registered Medicines. The update...

Careers @ MCAZ

30 October 2018

The Medicines Control Authority of Zimbabwe (MCAZ) is inviting suitably qualified, honest, self-motivated applicants for the following post: REGULATORY OFFICER x1 POST - LICENSING AND ENFORCEMENT DIVISION Reporting to the...

Fellowship in regulatory science for African Medicine Reviewers/Assessors

26 October 2018
Fellowship in regulatory science for African Medicine Reviewers/Assessors

  Background   The Medicines Control Authority of Zimbabwe (MCAZ) Regional Centre of Regulatory Excellence (ReCORE) in partnership with the European and Developing Countries Clinical Trials Partnership (EDCTP) is offering...

Quality Policy Statement

06 July 2018
Quality Policy Statement

The Quality Policy of the Medicines Control Authority of Zimbabwe (MCAZ) is to ensure the provision of accurate and timeous services, continuously meet requirements of our customers and guarantee patient...

MCAZ Newsletter

10 May 2018
MCAZ Newsletter

In this issue: MCAZ turns 20 years Basics of reporting Side Effects of medicines Electronic Adverse Drug Reaction Reporting   For more information Please click here to download the Newsletter...

Medicines Information Bulletin - 2018

02 February 2018
Medicines Information Bulletin - 2018

Increased Reporting from the Targeted Spontaneous Reporting (TSR) Programme Click here to download the 2018 Drug Information Bulletin